cytarabine and goserelin

cytarabine has been researched along with goserelin in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Gandhok, N; Sartor, O	1
Bell, C; Bighin, C; Boni, L; Catzeddu, T; Clavarezza, M; Del Mastro, L; Sertoli, MR; Testa, D; Venturini, M	1

Reviews

1 review(s) available for cytarabine and goserelin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for cytarabine and goserelin

Article	Year
Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:1 Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Epirubicin; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Menopause; Menopause, Premature; Menstrual Cycle; Middle Aged; Ovary; Premenopause; Prospective Studies	2006

Article

Year

Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients.

Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:1

Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Epirubicin; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Menopause; Menopause, Premature; Menstrual Cycle; Middle Aged; Ovary; Premenopause; Prospective Studies

2006

Other Studies

1 other study(ies) available for cytarabine and goserelin

Article	Year
Unexpected response of hormone-refractory prostate cancer to treatment with an antileukemic chemotherapy regimen. Urology, 2004, Volume: 64, Issue:4 Topics: Adenocarcinoma; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Fatal Outcome; Goserelin; Humans; Immunocompromised Host; Male; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasms, Second Primary; Neutropenia; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostate-Specific Antigen; Prostatic Neoplasms; Recurrence; Sepsis; Tosyl Compounds; Vincristine	2004

Article

Year

Unexpected response of hormone-refractory prostate cancer to treatment with an antileukemic chemotherapy regimen.

Urology, 2004, Volume: 64, Issue:4

Topics: Adenocarcinoma; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Fatal Outcome; Goserelin; Humans; Immunocompromised Host; Male; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasms, Second Primary; Neutropenia; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostate-Specific Antigen; Prostatic Neoplasms; Recurrence; Sepsis; Tosyl Compounds; Vincristine

2004